Main Text
Infantile hypertrophic pyloric stenosis (IHPS [MIM #179010]) is the most common cause of gastrointestinal obstruction in the first few months of life, with an incidence of 1-8 per 1000 live births in the white population. It typically presents in infants 2-6 weeks after birth with projectile vomiting, weight loss, and dehydration. Surgical treatment by pyloromyotomy was introduced a century ago. A genetic predisposition to IHPS is well established. IHPS shows familial aggregation, and the classic studies of Carter defined the disease as a paradigm for the multifactorial sex-modified threshold model of inheritance, with affected males outnumbering females in a 4:1 ratio. This male preponderance was confirmed by later studies in various populations.
There is a striking variation in incidence between population groups, with the cumulative incidence in American infants being 1.9 per 1000 live births in whites, 1.8 in Hispanics, 0.7 in blacks, and 0.6 in Asians.
In a reanalysis of data from several studies, λ (the ratio of the disease risk among patient siblings to that among members of the general population) was estimated to be 18. The same study concluded that IHPS is determined by two or three loci of moderate effect conferring individual genotype relative risks (GRRs) of up to 5.
IHPS has also been associated with several genetic syndromes, such as Cornelia de Lange and SmithLemli-Opitz syndromes, and chromosomal abnormalities, including translocation of chromosome 8 and 17 and a partial trisomy of chromosome 9.
Autosomal-dominant monogenic forms of IHPS have also been reported in several extended pedigrees.
A region on chromosome 16p13-p12 has been identified as the first locus for monogenic IHPS (IHPS2 [MIM #610260]). A second locus for monogenic IHPS on chromosome 16q24 has since been identified (K.V.E., F.C., C.G., B.A.C., A.R., A.P., P.P., R.M.G., and E.M.K.C., unpublished data). The gene encoding neuronal nitric oxide synthase, NOS1 (MIM #163731), on chromosome 12q is also considered to be an IHPS susceptibility locus (IHPS1 [MIM #179010]).
Environmental factors are clearly implicated in the development of IHPS. A period of postnatal enteral feeding is required for the disease to develop. In addition, a recent decline in the incidence of IHPS that parallels that of sudden infant death has been observed, coinciding with the implementation of the "back to sleep campaign" . This has led to the suggestion that posture and feeding are two important potentially modifiable environmental factors in IHPS. A further environmental factor in some cases is erythromycin, a motilin agonist. A 7-fold increase in the incidence of IHPS has been reported among newborn infants who had received erythromycin for postexposure pertussis prophylaxis. Erythromycin binds to the motilin receptor, which is expressed in the enteric neurons of the duodenum and colon, and induces intestinal contractions. It is administered in low doses to improve gastric emptying, but when used in higher doses as an antibiotic, it can lead to prolonged contraction and hypertrophy.
The aim of this work was the identification of disease-predisposing loci with a genome-wide SNP-based linkage scan in a resource of IHPS pedigrees. A SNP-based approach provides increased genomic coverage and a greater overall information content in comparison to microsatellites.
A model-free nonparametric analysis was initially performed, followed by specific parametric analyses.
Eighty-one pedigrees, all of European descent, were ascertained from the UK and Ireland via pediatric units in four major centers: St George's Healthcare National Health Service (NHS) Trust, London; Great Ormond Street Hospital for Children NHS Trust, London; Barts and the London NHS Trust; and Our Lady's Children's Hospital, Dublin. There were a total of 302 individuals, with 206 affected. This resource has sufficient power to detect loci of moderate effect in a subset of these pedigrees. Thirty-nine families had two affecteds; 25 had three affecteds; seven had four affecteds; eight had five affecteds; and two had seven affecteds. Full details are contained in the Supplemental Data available online. The ratio of male to female affecteds was 3 to 1. The diagnosis in all cases was confirmed at pyloromyotomy. The study was approved by the Ethics Committee of University College London Hospital and by the appropriate local insitutional review boards at all other participating hospitals. Informed consent was obtained from all participating families.
Genomic DNA was extracted from cheek swab, saliva, or blood samples according to standard kits and protocols (Oragene and Simhelix DNA Isolation kits). Samples were whole-genome ampliflied as required with the REPLI-g kit. Of the total 302 individuals included in the study, whole-genomeamplified DNA was used for 182 samples.
A genome-wide scan was carried out with the Illumina Linkage IV Panel of 6008 SNPs; 5942 SNPs (98.9%) were successfully typed. These SNPs are designed to be evenly distributed throughout the genome with an average genetic distance between SNPs of 0.64 cM and an average physical distance of 482 kb. Fifteen whole-genome amplification (WGA) samples (8.2%) could not be genotyped at all; none of the genomic DNA samples failed completely. This genotyping was performed by Illumina, San Diego CA.
Multipoint nonparametric linkage (NPL) analysis was performed with MERLIN 1.0.1. The Minx version of this software was used for the analysis of the X chromosome data. Thirteen of the 81 families in the resource were excluded by the program from X chromosome analysis because no part of the pedigree was consistent with X-linked inheritance (i.e., only male-to-male disease transmission occurred). MERLIN 1.0.1 checks for and removes erroneous genotypes prior to analysis. Z scores were derived at each SNP position along with a corresponding p value. The Z score is compared to a normal distribution to test for deviation. The assumption of a normal distribution is conservative, as are the associated p values. Thresholds for suggestive evidence for linkage and significant evidence for linkage were based on those proposed by Lander and Kruglyak but are slightly less stringent. Suggestive linkage in this study is defined by a p value less than 10 , and the threshold for significant linkage is a p value less than 10 . These values are equivalent to one-tailed Z scores of 3.1 and 3.7, respectively, which are themselves equivalent to maximized logarithm of odds (LOD) scores of 2.4 and 3.3.
The results of the multipoint NPL analysis for each chromosome are shown in Figure 1 . The X chromosome and chromosome 11 demonstrated significant evidence for linkage with an NPL Z of 4.3 (p < 0.00001) for the X chromosome and an NPL Z of 3.9 (p < 0.00005) for chromosome 11. A comparison of Z scores for each family for the "critical" regions on chromosome 11 and the X chromosome is given in the Supplemental Data. The critical region is arbitrarily defined as extending to where the Z score falls below 3. This is a conservative approach to defining the critical region so that no possible candidate genes are overlooked. Most families were consistent with linkage to either chromosome 11 or the X chromosome (or both); 12 families were not consistent with linkage to either locus. An expanded view of each linked region is shown in Figure 2 and detailed in Tables 1 and 2 . Haplotypes were derived with the MERLIN 1.0.1 best-estimate approach, which is based on the most likely pattern of gene flow. The pedigree structure and haplotypes for the linked regions for the most informative families is given in the Supplemental Data. Suggestive evidence for linkage with a Z of 3.1 (p < 0.001) was found at chromosome 22q11.1.
Parametric analysis, also with MERLIN 1.0.1, was performed on those genomic regions that showed significant evidence for linkage with NPL analysis (chromosomes 11 and X). A disease allele frequency of 0.001 and penetrance of 0.6 was assumed. A heterogeneity LOD score (HLOD) was derived at each SNP position with a corresponding alpha, where α equals the proportion of families demonstrating linkage to that locus. 
The genetic architecture of common familial traits that do not segregate in a Mendelian fashion is beginning to emerge with the increased power provided by completion of the human-genome and HapMap projects. As anticipated, the genetic basis of such complex traits covers a wide spectrum. The number of loci involved (oligo-to polygenicity), their effect size and mode of interaction, and the frequency and heterogeneity of causal alleles is clearly variable. Linkage-analysis strategies remain a valid approach for those traits for which there is reasonable expectation that loci of moderate effect exist, provided that family resources adequate to offset the erosion of power engendered by locus heterogeneity can be assembled.
Syndromic and monogenic forms of IHPS clearly exist, but the most common form segregates as a complex multifactorial trait. The male preponderance could not be explained solely by X-linked recessive inheritance because male-to-male transmission is frequently observed. Two loci for monogenic IHPS have been identified by SNP-based genome-wide scans in two different multigeneration pedigrees consistent with autosomal dominant inheritance: chromosome 16p13-p12 (IHPS2 [MIM #610260]) and chromosome 16q24 (K.V.E., F.C., C.G., B.A.C., A.R., A.P., P.P., R.M.G., and E.M.K.C., unpublished data).
Suggestive evidence of linkage between IHPS and an intragenic microsatellite polymorphism in NOS1 (MIM #163731) on chromosome 12q24.2-q24.31 was shown with 27 IHPS families from our resource, although this finding has not been replicated. More recently, an association between IHPS and a NOS1 promoter 1c regulatory polymorphism has been reported . The NOS1 gene encodes neuronal nitric oxide synthase (nNOS), an enzyme that catalyzes the formation of nitric oxide (NO) in neurons of the peripheral nervous system, where it plays a role in smooth-muscle relaxation. Transient pyloric relaxation is essential for the passage of stomach contents into the small bowel, and this is mainly mediated by the action of NO. A defect in NO production, leading to a failure of pyloric relaxation and subsequent alteration of luminal transit, was therefore proposed to underlie at least some cases of IHPS. NOS1-deficient mice are also reported to have features of IHPS. Consequently, NOS1 is considered to be a predisposing locus for IHPS (IHPS1 [MIM #179010]).
The statistical significance of linkage data generated by analysis of markers across the entire genome remains controversial, but thresholds adopted merely determine the extent to which investigators wish to tolerate false-positive results and waste resources in following up signals that have arisen by chance.
Nonparametric analysis was adopted initially so that potential problems in misspecification of inheritance parameters could be avoided. A parametric analysis was then carried out in those regions showing significant linkage. It can be argued that the similar results obtained suggest that the parameters chosen might be close to the true pattern of inheritance at these loci.
Adopting significance thresholds corresponding to those proposed by Lander and Kruglyak, we found evidence for significant linkage at chromosome 11q14-q22 and Xq23, and suggestive evidence of linkage was found at chromosome 22q. No evidence of linkage was obtained at the NOS1 locus (IHPS1 [MIM #179010]) on chromosome 12q24 or at the loci for monogenic IHPS on chromosome 16. This does not of course exclude that small-effect alleles at any of these loci might contribute to the trait in some or even all of these pedigrees. It is consistent with the infrequency with which loci for Mendelian forms of complex traits emerge as susceptibility loci for common cases. The results in any event confirm that locus heterogeneity exists for IHPS. Linkage 12 Mb on chromosome 11q14-q22 and approximately 2 Mb on chromosome Xq23 can be defined. The former encompasses about 100 known or predicted genes and the latter about 12 genes.
Knowledge of the underlying pathophysiology of IHPS is sufficiently advanced to allow evaluation of positional candidate genes within the critical regions according to their expression and putative function. Information was collected from a number of human-genome resources including the Ensembl, National Center for Biotechnology Information (NCBI), and University of California-Santa Cruz (UCSC) Browsers (genome build NCBI36.1), in addition to the PubMed and Unigene databases.
Smooth-muscle hypertrophy in the pyloric canal underlies the gastric-outlet obstruction in IHPS. This develops after birth and requires a period of enteral feeding. IHPS appears to arise from a defect in gastrointestinal motility that shows both development-and location-specific expression, rather than a defect in the developmental anatomy of the gastrointestinal tract. It is noteworthy that each of these two chromosomal regions harbors a gene from the same family of canonical transient receptor potential (TRPC) cation channels: TRPC6 on chromosome 11q21-22 and TRPC5 on chromosome Xq23. These genes represent the strongest functional candidate in each region.
Mammalian TRP proteins form a superfamily of 28 genes encoding six-transmembrane (6-TM) permeable cation-channel subunits grouped into six subfamilies by amino acid sequence homology. TRP channels are calcium-permeable cation channels and appear to act as signal integrators in a wide variety of biological contexts.
The canonical TRP channel subfamily has seven members. TRPC channel expression tends to be ubiquitous and abundant in brain and neural tissues, but TRPC5 and TRPC6 have been detected in tissues of the gut and smooth muscle cells. TRPC6 is known to be highly expressed in pulmonary and vascular smooth muscle, and a specific role in regulating smooth-muscle function is emerging for this channel.
Overexpression of TRPC6 is implicated in increased pulmonary smooth-muscle proliferation, and it is possible that there might be a similar effect on the smooth muscle cells of the pylorus. Furthermore, TRPC6 also acts as a sensor of membrane stretch, which could be important in the gastrointestinal tract for correct maintenance of peristalsis. TRPC6-deficient mice display increased vascular smooth muscle contractility, indicating a role for TRPC6 in control of smooth-muscle tone. Gain-of-function mutations in TRPC6 that enhance channel activity cause a proteinuric kidney disease, focal and segmental glomerulosclerosis (FSGS), but this does not exclude quite different pathology arising from allelic variants with different functional effects.
TRPC5 is predominantly expressed in the brain, but it is also detected in smooth muscle cells and in the stomach, where a role in gastrointestinal-tract muscle contraction has been proposed.
There is evidence that TRPC5 might be involved in cardiac-muscle hypertrophy, and it has been shown to be activated by nitric oxide, which is important in smooth-muscle relaxation in the gastrointestinal tract.
An X-linked recessive locus accounting for a subset of IHPS families could obviously contribute to the male preponderance in IHPS. In our resource of familial and sporadic cases, the ratio of males to females is more skewed among the sporadic population (3:1 and 5:1, respectively). It is difficult to quantify the potential contribution of X-linked recessive inheritance to male preponderance in our limited resource. However, within the pedigrees, the ratio of males to females is approximately 3.5:1 in families consistent with linkage to Xq23 and 2.5:1 in families consistent with autosomal linkage. In conclusion, our results confirm locus heterogeneity for IHPS and identify loci on chromosomes 11q and Xq. Strong functional candidate genes, TRPC5 and TRPC6, exist at these loci, and further work is required for the evaluation of their putative role by resequencing and SNP-based association studies in our resource of IHPS trios. 
